Xeris Biopharma Holdings, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Xeris Biopharma Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q3 2024.
  • Xeris Biopharma Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 149M shares, a 7.92% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 149M +10.9M +7.92% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 149M +10.9M +7.92% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 148M +10.9M +7.96% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 138M +1.86M +1.36% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 138M +2.11M +1.55% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 138M Jun 30, 2023 10-Q 2023-08-08
Q1 2023 137M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 136M +11.4M +9.13% Dec 31, 2022 10-K 2024-03-06
Q3 2022 136M +69.5M +104% Sep 30, 2022 10-Q 2022-11-09
Q4 2021 125M +65.3M +109% Dec 31, 2021 10-K 2023-03-08
Q3 2021 66.5M Sep 30, 2021 10-Q 2021-11-10
Q4 2020 59.6M Dec 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.